Chronic widespread pain and fibromyalgia: Should reports of increased mortality influence management?
- Gary J. MacfarlaneAffiliated withEpidemiology Group, University of Aberdeen, Department of Public Health, School of Medicine
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
There have been few studies examining whether persons with chronic widespread pain or fibromyalgia are at increased risk for dying prematurely. Among the studies conducted there is little consistency in results. If there is an increased mortality risk, it is of the order of a 30% excess and it may be related to the lifestyle of patients with these symptoms, including lack of exercise. Skilled judgment is required in determining whether reports of new symptoms are likely to indicate underlying new pathology. Studies are currently underway which will determine whether initial observations of an increased mortality risk can be replicated.
- Chronic widespread pain and fibromyalgia: Should reports of increased mortality influence management?
Current Rheumatology Reports
Volume 7, Issue 5 , pp 339-341
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links
- Author Affiliations
- 1. Epidemiology Group, University of Aberdeen, Department of Public Health, School of Medicine, Polwarth Building, AB25 2ZD, Aberdeen, Scotland, UK